Cargando…
Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
In December 2019, a severe outbreak of a novel coronavirus (COVID-19) occurred in the whole world, posing a great threat to people’s health. With the outbreak and development of the epidemic, how to improve the cure rate, find effective drugs against this virus, has been the most urgent problem. Chl...
Autores principales: | Chen, Yan, Shen, TaiPeng, Zhong, LiJun, Liu, ZhiXi, Dong, XinWei, Huang, TingWenLi, Wang, QiuJu, Xiao, HongTao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412992/ https://www.ncbi.nlm.nih.gov/pubmed/32848774 http://dx.doi.org/10.3389/fphar.2020.01167 |
Ejemplares similares
-
Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia
por: Chen, Yan, et al.
Publicado: (2020) -
Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
por: Huang, Lu, et al.
Publicado: (2022) -
The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
por: Manivannan, Elangovan, et al.
Publicado: (2021) -
Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis
por: Ren, Lu, et al.
Publicado: (2020) -
Ontology-Based Classification and Analysis of Adverse Events Associated With the Usage of Chloroquine and Hydroxychloroquine
por: Ngai, Jamie, et al.
Publicado: (2022)